Vaccinex, Inc. (VCNX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$16.21M
Year ended 2024-12-31
2017-12-31: -$21.45M2018-12-31: -$25.51M2019-12-31: -$30.79M2020-12-31: -$28.94M2021-12-31: -$25.33M2022-12-31: -$19.17M2023-12-31: -$21.45M2024-12-31: -$16.21M-$16.21M
2017-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$16.21Mn/m2025-04-15, From 2024-01-01
2023-12-31-$21.45Mn/c2025-04-15, From 2023-01-01
2022-12-31-$19.17Mn/m2024-04-25, From 2022-01-01
2021-12-31-$25.33Mn/m2023-03-31, From 2021-01-01
2020-12-31-$28.94Mn/m2022-03-31, From 2020-01-01
2019-12-31-$30.79Mn/m2021-03-31, From 2019-01-01
2018-12-31-$25.51Mn/m2020-03-09, From 2018-01-01
2017-12-31-$21.45Mn/a2019-03-13, From 2017-01-01